FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/11/022181 [Registered on: 27/11/2019] Trial Registered Prospectively
Last Modified On: 20/05/2026
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Other 
Public Title of Study   Body composition assessment in children with Acute Lymphoblastic Leukaemia (ALL) during cancer treatment 
Scientific Title of Study   Accurate estimation of changes in body composition, energy balance and nutritional status of Indian children with Acute Lymphoblastic Leukaemia (ALL) during cancer treatment 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
236/2019  Other 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Tony D S Raj 
Designation  Dean, Professor 
Affiliation  St John s Research Institute 
Address  Professor of Physiology St John s Medical College, Head, Division of Medical Informatics, Dean s Office, St John s Research Institute, St John s National Academy of Health Sciences Koramangala

Bangalore
KARNATAKA
560034
India 
Phone  08049467000  
Fax    
Email  tonyraj@sjri.res.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Tony D S Raj 
Designation  Dean, Professor 
Affiliation  St John s Research Institute 
Address  Professor of Physiology St John s Medical College, Head, Division of Medical Informatics, Dean s Office, St John s Research Institute, St John s National Academy of Health Sciences Koramangala

Bangalore
KARNATAKA
560034
India 
Phone  08049467000  
Fax    
Email  tonyraj@sjri.res.in  
 
Details of Contact Person
Public Query
 
Name  Dr Tony D S Raj 
Designation  Dean, Professor 
Affiliation  St John s Research Institute 
Address  Professor of Physiology St John s Medical College, Head, Division of Medical Informatics, Dean s Office, St John s Research Institute, St John s National Academy of Health Sciences Koramangala

Bangalore
KARNATAKA
560034
India 
Phone  08049467000  
Fax    
Email  tonyraj@sjri.res.in  
 
Source of Monetary or Material Support  
International Atomic Energy Agency Vienna International Centre PO Box 100 1400 Vienna, Austria Tel (431) 26000 Fax (431) 26007 
 
Primary Sponsor  
Name  International Atomic Energy Agency 
Address  Vienna International Centre PO Box 100 1400 Vienna Austria 
Type of Sponsor  Other [Intergovernmental forum for scientific and technical co-operation in the nuclear field] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Tony D S Raj  St John s Research Institute  Division of Nutrition, Body composition lab, SJRI Admin Block, St John s Research Institute St Johns National Academy of Health Sciences John Nagar Koramangala
Bangalore
KARNATAKA 
08049467000

tonyraj@sjri.res.in 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
St John s Medical College Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied
Modification(s)  
Health Type  Condition 
Healthy Human Volunteers  Normal healthy children as controls in the age of 2-10 years 
Patients  (1) ICD-10 Condition: C910||Acute lymphoblastic leukemia [ALL],  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
 
Inclusion Criteria
Modification(s)  
Age From  2.00 Year(s)
Age To  10.00 Year(s)
Gender  Both 
Details  Newly detected cases of children with acute lymphoblastic leukaemia
Age range 2 to 10 years

Normal healthy children in the age of 2 to 10 as control subjects

 
 
ExclusionCriteria 
Details  Conditions such as diabetes, hormonal problems which could affect body composition
Children with sepsis causing hemodynamic compromise and who cannot be assessed.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Novel data providing accurate body composition measurements (BCM and Fat) at baseline along with data on the changes occurring in body composition in children with ALL in India.
 
End of treatment phase
 
 
Secondary Outcome  
Outcome  TimePoints 
Data on the dietary intake, physical activity and energy expenditure of children with ALL which will provide insights into the possible reasons for observed energy imbalance
 
End of treatment phase 
Assessment of frailty in children with ALL during treatment  End of treatment phase 
A predictive equation for BCM from simple anthropometric measurements that can be used widely.  End of treatment phase 
Estimates of hydration and density of FFM in children with ALL.   End of treatment phase 
Information that can be used by professionals to tailor nutritional intervention and ensure the best outcome in oncology patients.   End of treatment phase 
 
Target Sample Size
Modification(s)  
Total Sample Size="58"
Sample Size from India="58" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   22/09/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial
Modification(s)  
Years="7"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   The incidence of paediatric cancer is on the rise with the global prevalence being 14.9 per million. Acute Lymphoblastic Leukemia (ALL) is the most common childhood cancer and these children have increased complications during the treatment leading to poor nutritional status and reduced quality of life. The aim of the proposed study is to accurately measure the body composition (body cell mass and fat mass) of children with ALL at diagnosis and during the various stages of chemotherapy & to evaluate the role of diet and physical activity. The findings of the proposed study will provide novel baseline information on the body composition in Indian children with ALL, along with data on the changes occurring in body composition and energy balance during treatment. The data on energy intake and expenditure will provide insights into the possible reasons for energy imbalance.  The proposed study, for the first time will provide data on the composition of fat free mass (FFM) in children with ALL and estimates of the changes in the composition of FFM during treatment in Indian children.  These findings will have clinical relevance in the management of fast mass gain in ALL survivors 
Close